Publications by authors named "Robert Call"

Claim this Profile
S
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial.
Kara W Chew, Babafemi O Taiwo, Carlee Moser, Eric S Daar, David Alain Wohl, Robert Call

J Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Citrate does not change viscoelastic haemostatic assays after cardiopulmonary bypass.
Benjamin M Kristobak, Margaret L McCarthy, Ryan J Keneally, Keith D Amberman, Harvey J Ellis, Robert C Call

Ann Card Anaesth· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Maximum-Use Trial of Ruxolitinib Cream in Adolescents and Adults with Atopic Dermatitis.
Robert Bissonnette, Robert S Call, Tooraj Raoof, Zhaoyin Zhu, Swamy Yeleswaram

Am J Clin Dermatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
Ann R Falsey, Magdalena E Sobieszczyk, Ian Hirsch, Stephanie Sproule, Merlin L Robb, Robert Call

N Engl J Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Should We Stick with Surgical Glues? The Incidence of Dermatitis after 2-Octyl Cyanoacrylate Exposure in 102 Consecutive Breast Cases.
Lauren Nigro, Robert Call, Nadia Blanchet

Plast Reconstr Surg· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.
Lawrence F Eichenfield, Robert S Call, Douglass W Forsha, Joseph Fowler, Adelaide A Hebert

J Am Acad Dermatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
Amy S Paller, Wynnis L Tom, Mark G Lebwohl, Robin L Blumenthal, Mark Boguniewicz, Robert S Call

J Am Acad Dermatol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open-Label, Maximal-Use Systemic Exposure Study.
Lee T Zane, Leon Kircik, Robert Call, Eduardo Tschen, Zoe Diana Draelos

Pediatr Dermatol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth and Post-Deposition Treatments of SrTiO3 Films for Dye-Sensitized Photoelectrosynthesis Cell Applications.
Robert W Call, Leila Alibabaei, Robert J Dillon, Robin R Knauf, Animesh Nayak

ACS Appl Mater Interfaces· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
Piyush Patel, George Philip, William Yang, Robert Call, Friedrich Horak

Ann Allergy Asthma Immunol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis